Go Pro
→ Wall Street is staring at the wrong AI trade (From The Oxford Club) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVRx, Inc. stock logo
CVRX
CVRx
$3.08
+4.8%		$4.92
$2.20
▼
$11.30
$78.33M0.811.31 million shs1.89 million shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$4.41
-0.9%		$4.03
$2.20
▼
$5.42
$267.47M0.5186,245 shs142,769 shs
Profound Medical stock logo
PROF
Profound Medical
$6.63
-0.6%		$7.01
$3.76
▼
$8.95
$242.39M0.73124,022 shs100,414 shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$7.85
-2.0%		$4.84
$3.22
▼
$8.55
$246.52M1.86639,669 shs270,938 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVRx, Inc. stock logo
CVRX
CVRx
+7.69%-50.51%-43.02%-50.92%-61.92%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
+0.68%+7.23%+20.60%+19.62%+67.29%
Profound Medical stock logo
PROF
Profound Medical
-3.75%-15.99%-6.06%-4.30%+22.39%
Avita Medical Inc. stock logo
RCEL
Avita Medical
-1.35%+68.63%+99.25%+75.66%+39.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVRx, Inc. stock logo
CVRX
CVRx
$3.08
+4.8%		$4.92
$2.20
▼
$11.30
$78.33M0.811.31 million shs1.89 million shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$4.41
-0.9%		$4.03
$2.20
▼
$5.42
$267.47M0.5186,245 shs142,769 shs
Profound Medical stock logo
PROF
Profound Medical
$6.63
-0.6%		$7.01
$3.76
▼
$8.95
$242.39M0.73124,022 shs100,414 shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$7.85
-2.0%		$4.84
$3.22
▼
$8.55
$246.52M1.86639,669 shs270,938 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVRx, Inc. stock logo
CVRX
CVRx
+7.69%-50.51%-43.02%-50.92%-61.92%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
+0.68%+7.23%+20.60%+19.62%+67.29%
Profound Medical stock logo
PROF
Profound Medical
-3.75%-15.99%-6.06%-4.30%+22.39%
Avita Medical Inc. stock logo
RCEL
Avita Medical
-1.35%+68.63%+99.25%+75.66%+39.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVRx, Inc. stock logo
CVRX
CVRx
2.33
Hold$6.90124.03% Upside
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
2.63
Moderate Buy$13.00194.78% Upside
Profound Medical stock logo
PROF
Profound Medical
2.67
Moderate Buy$11.5073.45% Upside
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.57
Moderate Buy$8.255.10% Upside

Current Analyst Ratings Breakdown

Latest CVRX, OBIO, PROF, and RCEL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/11/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$9.00 ➝ $10.00
8/7/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Buy$7.00
8/7/2026
CVRx, Inc. stock logo
CVRX
CVRx
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweight ➝ Neutral$4.00
8/7/2026
CVRx, Inc. stock logo
CVRX
CVRx
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$4.00
8/7/2026
CVRx, Inc. stock logo
CVRX
CVRx
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$14.00 ➝ $3.50
8/3/2026
CVRx, Inc. stock logo
CVRX
CVRx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/29/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/27/2026
Profound Medical stock logo
PROF
Profound Medical
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeOutperform ➝ Strong-Buy$11.00
7/17/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/14/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVRx, Inc. stock logo
CVRX
CVRx
$56.65M1.45N/AN/A$0.75 per share4.11
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$33.48M7.92N/AN/A$0.32 per share13.78
Profound Medical stock logo
PROF
Profound Medical
$16.10M14.96N/AN/A$1.37 per share4.84
Avita Medical Inc. stock logo
RCEL
Avita Medical
$71.61M3.37N/AN/A($0.90) per share-8.72
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVRx, Inc. stock logo
CVRX
CVRx
-$53.31M-$1.98N/AN/AN/A-84.93%-152.35%-50.93%N/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$52.70M-$0.85N/AN/AN/A-184.60%-149.61%-54.15%N/A
Profound Medical stock logo
PROF
Profound Medical
-$42.57M-$0.98N/AN/AN/A-171.57%-63.03%-51.24%N/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$48.59M-$1.44N/AN/AN/A-56.96%N/A-78.53%N/A

Latest CVRX, OBIO, PROF, and RCEL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.3920-$0.38+$0.0120-$0.38$0.14 million$0.09 million
8/6/2026Q2 2026
CVRx, Inc. stock logo
CVRX
CVRx
-$0.5246-$0.53-$0.0054-$0.53$15.55 million$15.71 million
8/6/2026Q2 2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.2928-$0.25+$0.0428-$5.00$20.25 million$21.70 million
5/14/2026Q1 2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CVRx, Inc. stock logo
CVRX
CVRx
N/AN/AN/AN/AN/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/AN/AN/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
N/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVRx, Inc. stock logo
CVRX
CVRx
2.94
8.04
6.87
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
1.80
8.26
7.01
Profound Medical stock logo
PROF
Profound Medical
N/A
6.46
5.31
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/A
0.41
0.34

Institutional Ownership

CompanyInstitutional Ownership
CVRx, Inc. stock logo
CVRX
CVRx
75.27%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
53.20%
Profound Medical stock logo
PROF
Profound Medical
47.86%
Avita Medical Inc. stock logo
RCEL
Avita Medical
27.66%

Insider Ownership

CompanyInsider Ownership
CVRx, Inc. stock logo
CVRX
CVRx
16.60%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
7.50%
Profound Medical stock logo
PROF
Profound Medical
1.52%
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVRx, Inc. stock logo
CVRX
CVRx
16026.64 million22.22 millionOptionable
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
460.10 million55.60 millionNot Optionable
Profound Medical stock logo
PROF
Profound Medical
15036.34 million35.79 millionOptionable
Avita Medical Inc. stock logo
RCEL
Avita Medical
13030.78 million30.09 millionOptionable

Recent News About These Companies

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript
August 13 at 8:16 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/avita-medical-rcel-q2-2026-221541448.html
AVITA Medical to Host Investor Webinar Briefing
August 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/09/3341503/0/en/avita-medical-to-host-investor-webinar-briefing.html
Avita Medical (NASDAQ:RCEL) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/avita-medical-nasdaqrcel-releases-quarterly-earnings-results-beats-estimates-by-004-eps-2026-08-08/
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven
August 7, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/avita-medical-reports-second-quarter-results-raises-2026-revenue-guidance-and-expects-fourth-quarter-cash-flow-breakeven-1036422648
Avita Medical shares surge after record second-quarter performance
August 7, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/avita-medical-shares-surge-after-record-second-quarter-performance/ar-AA29BFql
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
August 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341101/0/en/avita-medical-announces-participation-at-canaccord-genuity-growth-conference.html
Avita Medical Q2 Earnings Call Highlights
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/avita-medical-q2-earnings-call-highlights-2026-08-07/
AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4932718-avita-medical-inc-rcel-q2-2026-earnings-call-transcript
Avita Medical (RCEL) Projected to Post Quarterly Earnings on Thursday
August 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30942796
Wall Street Zen Upgrades Avita Medical (NASDAQ:RCEL) to "Hold"
August 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wall-street-zen-upgrades-avita-medical-nasdaqrcel-to-hold-2026-08-02/
Avita Medical (RCEL) Projected to Announce Earnings on Thursday
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/avita-medical-rcel-projected-to-announce-earnings-on-thursday-2026-07-30/
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Brokerages
July 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/avita-medical-inc-nasdaqrcel-receives-consensus-recommendation-of-hold-from-brokerages-2026-07-25/
Avita Medical (NASDAQ:RCEL) Downgraded to "Sell" Rating by Wall Street Zen
July 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/avita-medical-nasdaqrcel-downgraded-to-sell-rating-by-wall-street-zen-2026-07-25/
Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)
July 24, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TEM/pressreleases/3411481/analysts-are-neutral-on-these-healthcare-stocks-cencora-cor-avita-medical-rcel/
AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum
July 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/avita-medical-rcel-stock-sees-161417777.html
AVITA Medical to Announce Second Quarter 2026 Financial Results
July 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/14/3327257/0/en/avita-medical-to-announce-second-quarter-2026-financial-results.html
Avita Medical (RCEL) Upgraded to Buy: Here's Why
July 3, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2947957/avita-medical-rcel-upgraded-to-buy-here-s-why?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2947957
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
June 18, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/avita-medical-highlights-first-u-k-clinical-experience-with-recell-go-at-british-burn-association-annual-meeting-1036259517
Avita Medical (NASDAQ:RCEL) Director Purchases $20,800.00 in Stock
June 11, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rcel-insider-buying-and-selling-2026-06-11/
Avita Medical (NASDAQ:RCEL) Director Purchases $41,900.00 in Stock
June 10, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rcel-insider-buying-and-selling-2026-06-10/
Avita Medical (NASDAQ:RCEL) Director Purchases $40,900.00 in Stock
June 6, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rcel-insider-buying-and-selling-2026-06-06/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Data center aisle with server racks, blue lighting, and coolant supply and return pipes with gauges.
3 Stocks That Prove the AI Trade Isn't Over, It Moved
By Bridget Bennett | August 5, 2026
General Electric (GE) logo displayed on glass panel with wind turbines and solar panels in the background.
GE Vernova’s AI Power Boom Faces a Profit Test
By Peter Frank | August 12, 2026
TSMC logo displayed on a silicon wafer against a background of a patterned semiconductor chip surface.
TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
By Leo Miller | July 17, 2026
Server-room workstation with a volatility chart and a risk gauge highlights market turbulence and investor sentiment.
Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
By Dan Schmidt | July 26, 2026
Interior of a Dick's Sporting Goods store showing shelves of basketballs, gloves, and a wall of shoes.
Can DICK'S Turn Foot Locker Into a Winner?
By Peter Frank | August 9, 2026
CVRx stock logo

CVRx NASDAQ:CVRX

$3.08 +0.14 (+4.76%)
Closing price 04:00 PM Eastern
Extended Trading
$3.01 -0.07 (-2.40%)
As of 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Orchestra BioMed stock logo

Orchestra BioMed NASDAQ:OBIO

$4.41 -0.04 (-0.90%)
Closing price 04:00 PM Eastern
Extended Trading
$4.41 0.00 (0.00%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Profound Medical stock logo

Profound Medical NASDAQ:PROF

$6.63 -0.04 (-0.60%)
Closing price 04:00 PM Eastern
Extended Trading
$6.62 0.00 (-0.08%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Avita Medical stock logo

Avita Medical NASDAQ:RCEL

$7.85 -0.16 (-2.00%)
Closing price 04:00 PM Eastern
Extended Trading
$8.01 +0.16 (+1.99%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas